Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468481 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study for an Oral Contraceptive Containing Folate
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 385
- Enrollment target
NCT00468481: Completed Phase 3 study, sponsored by Bayer.
NCT00468481 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 385 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00468481, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 385 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the study drug is safe and effective
Primary Outcome
RBC folate=(\[whole blood folate\*100\]-\[plasma folate\*(100-hematocrit)\])/hematocrit
Interventions
- DRUG Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
- DRUG Drospirenone/Ethinylestradiol (Yaz)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
What the finished NCT00468481 record still lists
NCT00468481 is an interventional study that assigns participants to a tested intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which Drospirenone/Ethinylestradiol/Methyltetrahydrofolate is the first listed.
NCT00468481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00468481 about?
NCT00468481 is a clinical study titled "Efficacy and Safety Study for an Oral Contraceptive Containing Folate". The purpose of this study is to determine whether the study drug is safe and effective
What is the current status of trial NCT00468481?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 385 participants. The study started on 2007-04. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00468481?
The interventions under investigation include: Drospirenone/Ethinylestradiol/Methyltetrahydrofolate (DRUG), Drospirenone/Ethinylestradiol (Yaz) (DRUG).
Who is sponsoring clinical trial NCT00468481?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00468481's enrollment target sits among peer trials
385 975th of 2000 higher than 1,026 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia